84
87
Growth Score
3 pts
Heat Score
22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
349292
ELIXIR Pharmatech is a bio-drug development company that develops immuno-inflammation suppression drugs.
- Dong Yun Lee: Founder & CEO
About the Company
Elixir Pharmatech is a biopharmaceutical startup developing treatments for immune-inflammatory diseases, particularly inflammatory bowel disease (IBD). The company focuses on small-molecule therapeutics targeting the HMGB1 protein to suppress inflammatory responses and improve mucosal healing. Founded as a Hanyang University laboratory startup,
Elixir Pharmatech develops next-generation biomedicines and has participated in programs such as Deep Tech TIPS and early-stage startup support initiatives.
